diabetes

Analysis Shows Eli Lilly’s Half-Price Humalog Generic Is Not Readily Available Across the U.S.
BioSpace
Thu, 08/29/19 - 08:16 pm
diabetes
insulin
Humalog
generics
Eli Lilly
Lispro
Novo Nordisk and Mylan Battle Over Generic Versions of Victoza
BioSpace
Thu, 08/22/19 - 05:01 pm
Novo Nordisk
Mylan
generics
Victoza
diabetes
Most insurers don't cover Eli Lilly's half-priced insulin
Beckers Hospital Review
Mon, 08/12/19 - 05:30 pm
insulin
diabetes
drug pricing
Eli Lilly
PBMs
insurers
Sanofi ends partnership with Lexicon after trial failure
In-Pharma Technologist
Mon, 08/5/19 - 10:45 pm
Sanofi
Lexicon Pharmaceuticals
clinical trials
Zynquista
diabetes
Eli Lilly confirms probe by New York’s Attorney General over insulin prices
CNBC
Mon, 08/5/19 - 10:34 pm
Eli Lilly
drug pricing
insulin
diabetes
New York
New York investigating 3 insulin makers' pricing strategies
Beckers Hospital Review
Tue, 07/30/19 - 11:09 pm
New York
insulin
diabetes
Sanofi
Eli Lilly
Novo Nordisk
Sanofi ends partnership with Lexicon to develop add-on pill for diabetes
Yahoo/Reuters
Sat, 07/27/19 - 01:58 pm
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
type 2 diabetes
diabetes
insulin
As for Abbott's Libre, 'You Ain't Seen Nothin' Yet'
Medical Devices and Diagnostics Industry
Thu, 07/18/19 - 11:38 pm
Abbott Labs
Miles White
devices
FreeStyle Libre
blood glucose monitoring
diabetes
3 Top Diabetes Stocks to Watch in July
Motley Fool
Mon, 07/15/19 - 07:04 pm
diabetes
devices
DexCom
Insulet
Tandem Diabetes Care
Semma steps toward the clinic after demonstrating effect of potential diabetes cure in landmark animal studies
Endpoints
Sun, 06/30/19 - 01:15 pm
Semma Therapeutics
diabetes
Fresh analysis spotlights cardio benefit of J&J's Invokana in diabetes patients without history of CV disease
Endpoints
Wed, 06/12/19 - 10:02 am
JNJ
Invokana
ADA
diabetes
cardiovascular disease
Novo Nordisk goes for broke on semaglutide heart data
Biopharma Dive
Tue, 06/11/19 - 06:01 pm
Novo Nordisk
diabetes
FDA
Ozempic
oral semaglutide
ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study
Fierce Pharma
Tue, 06/11/19 - 12:06 pm
Eli Lilly
Boehringer Ingelheim
ADA
diabetes
Tradjenta
Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
Biopharma Dive
Mon, 06/10/19 - 07:34 pm
Sanofi
diabetes
ADA
Soliqua
clinical trials
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
Fierce Pharma
Mon, 06/10/19 - 09:27 am
Eli Lilly
ADA
diabetes
heart attack
stroke
Trulicity
Novo Nordisk
semaglutide
Beyond glucose in type 2 diabetes: how Novo Nordisk is looking to address chronic kidney disease
Pharmaforum
Wed, 06/5/19 - 12:01 am
Novo Nordisk
type 2 diabetes
diabetes
chronic kidney disease
Why Diabetes Stock Insulet Soared 27.3% in May
Motley Fool
Tue, 06/4/19 - 11:00 am
Insulet
diabetes
devices
Omnipod
Insulin Patch Earns Spot in American Diabetes Association Guidelines for Diabetes Care
Xtalks
Thu, 05/30/19 - 05:31 pm
diabetes
type 2 diabetes
insulin patch
ADA
Valeritas
V-Go
devices
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
Xconomy
Thu, 05/30/19 - 09:45 am
diabetes
microbiome
Whole Biome
Even as obesity rates climb, new diabetes cases fall
Stat
Tue, 05/28/19 - 11:54 am
diabetes
obesity

Pages